Author

Annelies Van Hemelryk

Vlaams Instituut voor BiotechnologieORCID 0000-0002-5071-9369Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Angeline Praveena Enton Raj· 1 shared Annika Jeschke· 1 shared Bram De WildeiD· 1 shared Ellen SandersiD· 1 shared Fanny De VloediD· 1 shared Fien Martens· 1 shared Frank SpelemaniD· 1 shared Iris H. NeleniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angeline Praveena Enton Raj

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitors

Iris H. Nelen, Soetkin Leys, Sarah-Lee Bekaert, Fanny De Vloed, Fien Martens, Ellen Sanders, Angeline Praveena Enton Raj, Annika Jeschke, Shunya Ohmura, Thomas G. P. Grünewald, Liselot M. Mus, Tim Lammens, Nadine Van Roy, Bram De Wilde, Frank Speleman, , Kaat Durinck

This study identifies synergistic effects of second-generation RRM2 and CHK1 inhibitors in neuroblastoma and sarcomas, showing enhanced replication stress and apoptosis.

Cell Death and Disease · Feb 25, 2026Peer-reviewedCancer Biology